NCT01926912 - A Study of Usage of Paliperidone Palmitate in Patients With Schizophrenia in a Hospital Setting | Biotech Hunter

Enrollment

371

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions

Schizophrenia

Interventions

DRUG

No intervention

This is an observational study. Participants prescribed with paliperidone palmitate by the treating physician as per local labeling information in the hospital setting will be observed and data will be collected.

Trial Locations (39)

Unknown

Diest

Saint-Servais

Tournai

Pazardzhik

Rousse

Sofia

Stara Zagora

Targovishte

Vratsa

Elsinore

København S

Berlin

Chemnitz

Dresden

Greifswald

Hamburg

Hennigsdorf

Neuruppin

Pfaffenhofen

Sachsen

Heraklion Crete

Ioannina

Katerini Pieria

Thessaloniki

Bat Yam

Tel Litwinsky

Almaty

Astana

Kyzylorda

Taraz

Ust-Kamenogorsk

Chelyabinsk

Moscow

Nizhny Novgorod

Omsk

Orenburg, Staritsa Village

Saint Petersburg

Tula Region

Yaroslavl